c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
STML
Stemline Therapeutics Inc
stock
NASDAQ
Inactive
Jun 9, 2020 4:00:00 PM EDT
11.83
USD
-1.417%
(-0.17)
Pre-market
After-hours
Overview
Company
Exchanges
Shorts
News
News
STML News
1
/
1
Oct 22, 2026
Day breaks
Nov 4, 2026
01:31 PM EST
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
·
PR Newswire
Oct 22, 2026
10:30 AM EDT
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
·
PR Newswire